This weekly post is for things that are not Omicron. For the Omicron news, see my Omicron updates (#1, #2, #3), the last of which came out the same day…
I have split off the Omicron post from the weekly post, which covers other aspects of Covid. I made judgment calls on where to put a few things. Omicro…
We now have some useful prediction markets up on Covid issues, so it’s worth looking at what they say and thinking about what other markets we could ge…
Opinions on whether Covid treatment should be legal differ
We know somewhat more now. The speed premium waits for no one.
It's been quite the day. Here's what we know so far.
For my first Thanksgiving post, which somehow was both a year ago and almost a year into the pandemic, I gave thanks at the end of the post. With all t…
I’ve split off this week’s Paxlovid update to help make the situation easier to notice, and easier to remember and reference later, lest we forget.
Trying out Substack as a potential primary place for the blog, let me know what you think.
This is Don't Worry About the Vase. Or rather, it’s the potential new home of Don’t Worry About the Vase, Zvi Mowshowitz’s blog. If the experiment is s…
and
Recently, a discussion of potential AGI interventions and potential futures was posted to LessWrong. The picture Eliezer presented was broadly consiste…
I was considering splitting off my analysis of the effectiveness of Pfizer's Paxlovid, a new Covid-19 treatment pill, but it's so straightforward there…